Adaptive Biotechnologies ADPT Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's other noncash income (expense)?
- Adaptive Biotechnologies (ADPT) reported other noncash income (expense) of -$14K in Q1 2026.
- How has Adaptive Biotechnologies's other noncash income (expense) changed year-over-year?
- Adaptive Biotechnologies's other noncash income (expense) increased by 81.6% year-over-year, from -$76K to -$14K.
- What is the long-term trend for Adaptive Biotechnologies's other noncash income (expense)?
- Over 2 years (2021 to 2025), Adaptive Biotechnologies's other noncash income (expense) has grown at a 176.4% compound annual growth rate (CAGR), from $80K to -$611K.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.